American Skin Association (ASA) announced on Wednesday that India-based pharmaceutical company Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA, BSE: 524715) has received its 2026 Corporate Leadership Award.
Howard P. Milstein, ASA chairman, said: "ASA is proud to present Sun Pharma with this well-deserved award for their dedication to the field of dermatology. Sun Pharma shares our dual mission of research and education, and we very much look forward to working together to find cures for skin diseases."
Though an educational grant from Sun Pharma, ASA launched a patient-facing podcast series in 2026 called SkinSight Podcast. The series breaks down common skin conditions, talks through real patient experiences, and offers insights from leading dermatology experts. Four episodes are now available for free on Apple Podcasts and Spotify.
Evogene completes Phase 1 study of BMC128 in combination with Nivolumab
FDA accepts Genentech's giredestrant application for early-stage breast cancer
Ansun Biopharma reports positive recommendation from independent DMC for DAS181
Amgen receives EU marketing authorisation for IMDYLLTRA in ES-SCLC
Haisco receives US FDA approval for anaesthetic Cipepofol
hVIVO secures Decoy Therapeutics consultancy contract for antiviral development
Rallybio and Avenzo Therapeutics announce merger agreement and USD215m financing
IBA launches Cyclone iKure for industrial-scale Astatine-211 production
Avacta reports encouraging early efficacy signals for AVA6000 in salivary gland cancer at ASCO 2026
TiumBio presents Phase 2a interim data for Tosposertib plus pembrolizumab at ASCO 2026
ImmVira reports 100% CRR at 9 months in bladder carcinoma in situ with MVR-T3011